Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Chris Bernene

Partner, Health & Life Sciences, Oliver Wyman

They Just Have to Persuade People to Like Them

Oliver Wyman research examines whether consumers are using healthcare’s “new front door”, and if not, why not.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Oliver Wyman's 2018 Consumer Survey explores healthcare's supply and demand disconnect.

Principal, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Imagine a world where fitness and providers work together to help consumers take more responsibility over their daily health decisions.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman
Associate, Oliver Wyman
Senior Consultant, Oliver Wyman

In the face of today’s market turmoil and revenue insecurity, ancillary products offer a stable, growing profit pool for health plans.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

What does the future hold for brokers? Fast track to dustbin of history or cemented place in new marketplace?

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Private exchanges are here to stay, say Oliver Wyman’s Chris Bernene and Howard Lapsley. Five reasons why payers should double down on private exchange strategy.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

In light of recent headlines, it may be time to take a step back—and a deep breath—to think about what drives the viability and adoption of disruptive healthcare business models.

Partner, Health & Life Sciences, Oliver Wyman